58971-11-2, name is 3-Bromophenethylamine, belongs to bromides-buliding-blocks compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows. SDS of cas: 58971-11-2
To a cooled (ice bath) solution of 3-bromophenethylamine (21 g, 105 mmol) and TEA (12.7 g, 125 mmol) in DCM (150 mL) was added dropwise trifluoroaceticanhydride (24 g, 115 mmol). The reaction was stirred at room temperature for18 h then poured into water (200 mL) and extracted with DCM (2 x 200 mL). The combined organic layers were concentrated then diluted with methyl tert-butyl ether (TBME) (250 mL) and H20 (50 mL). The layers were separated and the organic phase was washed with brine (50 mL) then dried over Na2504,filtered and concentrated to give crude N-(3-bromophenethyl)-O-(2,2,2-trifluoro- acetyl) hydroxylamine (33 g, >100%) as a brown solid. 1H NMR (400 MHz, DMSO-d6) O [ppm] 9.49 (br 5, 1H), 7.47- 7.35 (m, 2H), 7.30- 7.17 (m, 2H), 3.42 (d, J=4.0 Hz, 2H), 2.80 (t, J=7.0 Hz, 2H).
The synthetic route of 58971-11-2 has been constantly updated, and we look forward to future research findings.
Reference:
Patent; PFIZER INC.; ITEOS THERAPEUTICS; NINKOVIC, Sacha; CROSIGNANI, Stefano; SCALES, Stephanie Anne; MCALPINE, Indrawan James; COLLINS, Michael Raymond; MADERNA, Andreas; WYTHES, Martin; (295 pag.)WO2016/147144; (2016); A1;,
Bromide – Wikipedia,
bromide – Wiktionary